Accessing Treatment for Kidney Cancer
Update: December 10, 2015
Kidney Cancer Canada makes every attempt to track access to medications for kidney cancer in every province. The following information can be found in this section to help you navigate the treatments available in your Province/Territory as well and disseminate information on all approved treatments and the treatment guidelines for kidney cancer.
Drugs Approved by Health Canada for Kidney Cancer
This link provides information on all drugs approved by Health Canada for the treatment of kidney cancer. Please note that access to these treatments differs according to your province therefore you should be sure to read the section on Treatment Access Information by Province/Territory below.
Update on Access to Immuno-Oncology Treatments in Canada
Many patients and families are interested in the progress of immuno-oncology treatments as they apply to kidney cancer. Many of these treatments are in ongoing clinical trials across Canada. Kidney Cancer Canada is tracking all clinical trials and compassionate access programs. If you have any questions about how you can access treatments in your specific province, please contact us at 1 (866) 598-7166 or email@example.com.
More information on this link.
Treatment Access Information by Province/Territory
This link provides information about which drugs can you can access through the public programs in each province or territory. If you have private drug insurance, you may have additional options.
Kidney Cancer Treatment Guidelines
Canadian experts in kidney cancer have developed guidelines for the treatment of localized and advanced kidney cancer, and for screening of potentially hereditary kidney cancer. To view the guidelines, click here.
Drugs Available to Help Treat Specific Types of Metastases
Some patients may require additional drugs to treat specific types of metastases such as bone metastases related to renal cell carcinoma. Although some of these drugs are not specifically approved by Health Canada for metastatic renal cell carcinoma (mRCC) physicians may be able to prescribe these drugs because they have been approved by Health Canada for use with other types of cancer(s). Currently approved treatments are listed here.
As not all drugs are not currently available under the public formularies for mRCC, patients will need to investigate whether or not these drugs may be covered through their private insurance, by a special access program in their province, or through a clinical trial. Remember to speak first with your oncologist who will best know whether this treatment could be helpful to you.
Current Advocacy Campaigns
Not all treatments are available in every province and not all patients are eligible for coverage. Join our ongoing campaign to ensure access for all Canadians regardless of province or insurance status.